Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: a multicenter phase II trial.
about
Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer.Pegylated liposomal doxorubicin in the management of ovarian cancerClinical trials with pegylated liposomal Doxorubicin in the treatment of ovarian cancerDOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancerPharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment.
P2860
Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: a multicenter phase II trial.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Association of pegylated lipos ...... a multicenter phase II trial.
@ast
Association of pegylated lipos ...... a multicenter phase II trial.
@en
type
label
Association of pegylated lipos ...... a multicenter phase II trial.
@ast
Association of pegylated lipos ...... a multicenter phase II trial.
@en
prefLabel
Association of pegylated lipos ...... a multicenter phase II trial.
@ast
Association of pegylated lipos ...... a multicenter phase II trial.
@en
P2093
P921
P1433
P1476
Association of pegylated lipos ...... a multicenter phase II trial.
@en
P2093
Alain Lortholary
Emmanuel Sevin
Florence Joly
Frank Priou
Hugues Bourgeois
J F Paitel
Karim Hamond
Michel Fabbro
P304
P356
10.1016/J.YGYNO.2009.09.036
P407
P577
2009-11-03T00:00:00Z